International Games System Co.,Ltd. (TPEX:3293)

Sage Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,590	2,843	942.92	8,525	3,474	1,907
Short-Term Investments	13,939	10,468	9,503	1,987	4,654	4,046
Trading Asset Securities	114.38	113.36	109.99	107.79	107.05	107.37
Cash & Short-Term Investments	16,643	13,424	10,556	10,620	8,235	6,060
Cash Growth	28.55%	27.17%	-0.60%	28.96%	35.90%	53.19%
Accounts Receivable	2,496	2,426	2,065	1,650	1,707	1,257
Other Receivables	80.35	79.27	47.99	13.93	11.26	7.87
Receivables	2,577	2,505	2,113	1,664	1,718	1,265
Inventory	146.8	147.01	124.24	110.74	138.38	96.79
Prepaid Expenses	85.51	91.32	43.24	41.94	34.3	-
Other Current Assets	57.45	112.21	93.69	77.9	72.33	72.83
Total Current Assets	19,510	16,280	12,930	12,515	10,198	7,494
Property, Plant & Equipment	2,863	3,376	1,080	1,085	1,116	1,140
Long-Term Investments	560.37	523.7	477.75	448.19	761.21	229.4
Other Intangible Assets	73.7	73.09	54.75	56.73	21.77	50.66
Long-Term Deferred Tax Assets	53.26	52.14	73.97	66.55	123.75	114.6
Other Long-Term Assets	2,312	1,819	1,835	9.38	13.49	26.85
Total Assets	25,372	22,124	16,451	14,180	12,234	9,055
Accounts Payable	37.7	54.19	91.68	53.38	66.86	38.22
Accrued Expenses	4,308	4,110	3,025	2,577	2,299	1,538
Current Portion of Leases	4.33	3.68	1.27	2.46	2.83	2
Current Income Taxes Payable	1,367	923.4	551.2	328.94	444.16	366.71
Current Unearned Revenue	293.97	281.1	274.72	235.28	173.4	165.61
Other Current Liabilities	8,365	269.25	229.13	227.68	156.87	155.64
Total Current Liabilities	14,376	5,642	4,173	3,424	3,143	2,266
Long-Term Leases	4.2	3.44	0.38	0.76	2.32	1.73
Long-Term Deferred Tax Liabilities	43.16	31.78	-	-	0.04	0.04
Other Long-Term Liabilities	2.5	4.16	4.16	1.66	-	-
Total Liabilities	14,483	5,739	4,255	3,517	3,262	2,394
Common Stock	2,818	2,818	1,409	1,409	704.5	704.5
Additional Paid-In Capital	317.28	317.28	317.28	317.28	317.28	317.28
Retained Earnings	7,338	12,883	10,156	8,658	7,394	5,614
Comprehensive Income & Other	412.73	363.62	309.75	275.32	542.81	11.72
Total Common Equity	10,886	16,382	12,192	10,660	8,959	6,647
Minority Interest	3	3.09	3.41	3.43	13.48	13.77
Shareholders' Equity	10,889	16,385	12,196	10,663	8,973	6,661
Total Liabilities & Equity	25,372	22,124	16,451	14,180	12,234	9,055
Total Debt	8.53	7.12	1.65	3.22	5.14	3.72
Net Cash (Debt)	16,635	13,417	10,554	10,617	8,230	6,056
Net Cash Growth	28.51%	27.12%	-0.59%	29.00%	35.89%	53.24%
Net Cash Per Share	58.31	47.08	37.02	36.58	28.78	21.09
Filing Date Shares Outstanding	281.8	281.8	281.8	281.8	281.8	281.8
Total Common Shares Outstanding	281.8	281.8	281.8	281.8	281.8	281.8
Working Capital	5,133	10,638	8,757	9,090	7,055	5,228
Book Value Per Share	38.63	58.13	43.27	37.83	31.79	23.59
Tangible Book Value	10,812	16,309	12,138	10,603	8,937	6,596
Tangible Book Value Per Share	38.37	57.87	43.07	37.63	31.72	23.41
Land	-	1,781	347.88	347.88	347.88	347.88
Buildings	-	2,015	1,124	1,122	1,119	1,118
Machinery	-	285.39	244.28	186.77	158.44	123.9
Construction In Progress	-	15.43	-	-	-	-

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.